Skip to content

Matthew M. Burke

Yale New Haven Hospital

1 paper in the Anchorcite directory, published in 2013, cited 4,287 times in total.

Research topics

Frequent co-authors

Papers

  1. Nivolumab plus Ipilimumab in Advanced MelanomaNew England Journal of Medicine · 2013 · 4,287 citations

    BACKGROUND: In patients with melanoma, ipilimumab (an antibody against cytotoxic T-lymphocyte-associated antigen 4 [CTLA-4]) prolongs overall survival, and nivolumab (an antibody against the programmed death 1 [PD-1] receptor) produced durable tumor regression in a phase 1 trial. On the basis…

Metadata from OpenAlex (CC0).